Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C May

Showing results (911-920 of 926) with videos related to

Pageof 93
Sort By:
Biorxiv : the Preprint Server for Biology|June 19, 2024
Inhibition of the Eukaryotic Initiation Factor-2-α Kinase PERK Decreases Risk of Autoimmune Diabetes in MiceCharanya Muralidharan, Fei Huang, Jacob R Enriquez, et al.
Bioorganic & Medicinal Chemistry|December 2, 2019
Preparation and biological evaluation of BACE1 inhibitors: Leveraging trans-cyclopropyl moieties as ligand efficient conformational constraintsLeonard L Winneroski, Jon A Erickson, Steven J Green, et al.
Journal of Medicinal Chemistry|June 3, 2021
Discovery and Early Clinical Development of LY3202626, a Low-Dose, CNS-Penetrant BACE InhibitorDavid L McKinzie, Leonard L Winneroski, Steven J Green, et al.
Cell Stem Cell|January 18, 2017
A Single-Cell Roadmap of Lineage Bifurcation in Human ESC Models of Embryonic Brain DevelopmentZizhen Yao, John K Mich, Sherman Ku, et al.
Cancers|March 29, 2023
Pragmatic, Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bone: The PROSPER Study Rationale and DesignBradford S Hoppe, Ivy A Petersen, Benjamin K Wilke, et al.
Mass Spectrometry Reviews|February 2, 2019
Recommendations for reporting ion mobility Mass Spectrometry measurementsValérie Gabelica, Alexandre A Shvartsburg, Carlos Afonso, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 24, 2024
A framework for translating tauopathy therapeutics: Drug discovery to clinical trialsHoward H Feldman, Jeffrey L Cummings, Adam L Boxer, et al.
Blood Cancer Discovery|September 25, 2020
Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on <i>MIR300</i> Antiproliferative and PP2A-Activating FunctionsGiovannino Silvestri, Rossana Trotta, Lorenzo Stramucci, et al.
Msphere|January 20, 2017
The Case for Adopting the "Species Complex" Nomenclature for the Etiologic Agents of CryptococcosisKyung J Kwon-Chung, John E Bennett, Brian L Wickes, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 23, 2015
The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humansPatrick C May, Brian A Willis, Stephen L Lowe, et al.
Pageof 93

Showing results (911-920 of 926) with videos related to

Sort By:
Pageof 93
Biorxiv : the Preprint Server for Biology|June 19, 2024
Inhibition of the Eukaryotic Initiation Factor-2-α Kinase PERK Decreases Risk of Autoimmune Diabetes in MiceCharanya Muralidharan, Fei Huang, Jacob R Enriquez, et al.
Bioorganic & Medicinal Chemistry|December 2, 2019
Preparation and biological evaluation of BACE1 inhibitors: Leveraging trans-cyclopropyl moieties as ligand efficient conformational constraintsLeonard L Winneroski, Jon A Erickson, Steven J Green, et al.
Journal of Medicinal Chemistry|June 3, 2021
Discovery and Early Clinical Development of LY3202626, a Low-Dose, CNS-Penetrant BACE InhibitorDavid L McKinzie, Leonard L Winneroski, Steven J Green, et al.
Cell Stem Cell|January 18, 2017
A Single-Cell Roadmap of Lineage Bifurcation in Human ESC Models of Embryonic Brain DevelopmentZizhen Yao, John K Mich, Sherman Ku, et al.
Cancers|March 29, 2023
Pragmatic, Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bone: The PROSPER Study Rationale and DesignBradford S Hoppe, Ivy A Petersen, Benjamin K Wilke, et al.
Mass Spectrometry Reviews|February 2, 2019
Recommendations for reporting ion mobility Mass Spectrometry measurementsValérie Gabelica, Alexandre A Shvartsburg, Carlos Afonso, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 24, 2024
A framework for translating tauopathy therapeutics: Drug discovery to clinical trialsHoward H Feldman, Jeffrey L Cummings, Adam L Boxer, et al.
Blood Cancer Discovery|September 25, 2020
Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on <i>MIR300</i> Antiproliferative and PP2A-Activating FunctionsGiovannino Silvestri, Rossana Trotta, Lorenzo Stramucci, et al.
Msphere|January 20, 2017
The Case for Adopting the "Species Complex" Nomenclature for the Etiologic Agents of CryptococcosisKyung J Kwon-Chung, John E Bennett, Brian L Wickes, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 23, 2015
The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humansPatrick C May, Brian A Willis, Stephen L Lowe, et al.
Pageof 93